Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature review
Cancer is a significant cause of death worldwide. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is spreading rapidly globally. Information on coronavirus disease 2019 (COVID-19) and its complications in cancer patients are still limited. It is relevant to consider that some...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2022-07-01
|
| Series: | Gaceta Mexicana de Oncología |
| Subjects: | |
| Online Access: | https://www.gamo-smeo.com/frame_esp.php?id=324 |
| _version_ | 1818058208421347328 |
|---|---|
| author | Christian O. Ramos-Peñafiel Erika A. Rosas-González Irma Olarte-Carrillo Mónica P. Bejarano-Rosales Karolina Álvarez-Altamirano Vanessa Fuchs-Tarlovsky Carlos Martínez-Murillo Adrián Santoyo-Sánchez Adolfo Martínez-Tovar |
| author_facet | Christian O. Ramos-Peñafiel Erika A. Rosas-González Irma Olarte-Carrillo Mónica P. Bejarano-Rosales Karolina Álvarez-Altamirano Vanessa Fuchs-Tarlovsky Carlos Martínez-Murillo Adrián Santoyo-Sánchez Adolfo Martínez-Tovar |
| author_sort | Christian O. Ramos-Peñafiel |
| collection | DOAJ |
| description | Cancer is a significant cause of death worldwide. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is spreading rapidly globally. Information on coronavirus disease 2019 (COVID-19) and its complications in cancer patients are still limited. It is relevant to consider that some chemotherapeutic agents have secondary immunosuppressive effects. Approximately 35% of hematologic cancer patients develop pneumonia caused by community respiratory viruses. People older than 65 years-old or with severe neutropenia or lymphopenia are at higher risk. Cancer patients with pneumonia infected by parainfluenza virus showed a higher risk of mortality compared to non-cancer patients (p < 0.05; 12.3% vs. 3.8%) or coronavirus infections (p < 0.01; 24% vs. 30%). Complications associated with SARS-COV2 infection in cancer patients are limited to descriptive studies, with those who received myeloablative, immunosuppressive or monoclonal antibody therapies being more susceptible.
|
| first_indexed | 2024-12-10T12:56:59Z |
| format | Article |
| id | doaj.art-dbc03ff7d63e41d8bd52ee3d5fdac620 |
| institution | Directory Open Access Journal |
| issn | 1665-9201 |
| language | English |
| last_indexed | 2024-12-10T12:56:59Z |
| publishDate | 2022-07-01 |
| publisher | Permanyer |
| record_format | Article |
| series | Gaceta Mexicana de Oncología |
| spelling | doaj.art-dbc03ff7d63e41d8bd52ee3d5fdac6202022-12-22T01:48:04ZengPermanyerGaceta Mexicana de Oncología1665-92012022-07-0121310.24875/j.gamo.22000179Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature reviewChristian O. Ramos-Peñafiel0Erika A. Rosas-González1Irma Olarte-Carrillo2Mónica P. Bejarano-Rosales3Karolina Álvarez-Altamirano4Vanessa Fuchs-Tarlovsky5Carlos Martínez-Murillo6Adrián Santoyo-Sánchez7Adolfo Martínez-Tovar8Hematology Department, Hospital General de México Dr. Eduardo Liceaga; National Research Department, Consejo Nacional de Ciencia y Tecnología (Conacyt); Mexico City, MexicoResearch Department in Clinical Nutrition, Hospital General de México Dr. Eduardo Liceaga, Mexico City, MexicoHematology Department, Hospital General de México Dr. Eduardo Liceaga; School of Medicine, UNAM; 6Molecular Biology Laboratory, Hospital General de México Dr. Eduardo Liceaga. Mexico City, MexicoResearch Department in Clinical Nutrition, Hospital General de México Dr. Eduardo Liceaga, Mexico City, MexicoResearch Department in Clinical Nutrition, Hospital General de México Dr. Eduardo Liceaga, Mexico City, MexicoNational Research Department, Consejo Nacional de Ciencia y Tecnología (Conacyt); Research Department in Clinical Nutrition, Hospital General de México Dr. Eduardo Liceaga; Mexico City, MexicoHematology Department, Hospital General de México Dr. Eduardo Liceaga, Mexico City, MexicoHematology Department, Hospital General de México Dr. Eduardo Liceaga; School of Medicine, UNAM; Mexico City, MexicoHematology Department, Hospital General de México Dr. Eduardo Liceaga; Molecular Biology Laboratory, Hospital General de México Dr. Eduardo Liceaga. Mexico City, MexicoCancer is a significant cause of death worldwide. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection is spreading rapidly globally. Information on coronavirus disease 2019 (COVID-19) and its complications in cancer patients are still limited. It is relevant to consider that some chemotherapeutic agents have secondary immunosuppressive effects. Approximately 35% of hematologic cancer patients develop pneumonia caused by community respiratory viruses. People older than 65 years-old or with severe neutropenia or lymphopenia are at higher risk. Cancer patients with pneumonia infected by parainfluenza virus showed a higher risk of mortality compared to non-cancer patients (p < 0.05; 12.3% vs. 3.8%) or coronavirus infections (p < 0.01; 24% vs. 30%). Complications associated with SARS-COV2 infection in cancer patients are limited to descriptive studies, with those who received myeloablative, immunosuppressive or monoclonal antibody therapies being more susceptible. https://www.gamo-smeo.com/frame_esp.php?id=324SARS-CoV-2. COVID-19. Cancer. Chemotherapy. |
| spellingShingle | Christian O. Ramos-Peñafiel Erika A. Rosas-González Irma Olarte-Carrillo Mónica P. Bejarano-Rosales Karolina Álvarez-Altamirano Vanessa Fuchs-Tarlovsky Carlos Martínez-Murillo Adrián Santoyo-Sánchez Adolfo Martínez-Tovar Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature review Gaceta Mexicana de Oncología SARS-CoV-2. COVID-19. Cancer. Chemotherapy. |
| title | Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature review |
| title_full | Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature review |
| title_fullStr | Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature review |
| title_full_unstemmed | Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature review |
| title_short | Novel coronavirus SARS-CoV-2 outbreak and cancer: A literature review |
| title_sort | novel coronavirus sars cov 2 outbreak and cancer a literature review |
| topic | SARS-CoV-2. COVID-19. Cancer. Chemotherapy. |
| url | https://www.gamo-smeo.com/frame_esp.php?id=324 |
| work_keys_str_mv | AT christianoramospenafiel novelcoronavirussarscov2outbreakandcanceraliteraturereview AT erikaarosasgonzalez novelcoronavirussarscov2outbreakandcanceraliteraturereview AT irmaolartecarrillo novelcoronavirussarscov2outbreakandcanceraliteraturereview AT monicapbejaranorosales novelcoronavirussarscov2outbreakandcanceraliteraturereview AT karolinaalvarezaltamirano novelcoronavirussarscov2outbreakandcanceraliteraturereview AT vanessafuchstarlovsky novelcoronavirussarscov2outbreakandcanceraliteraturereview AT carlosmartinezmurillo novelcoronavirussarscov2outbreakandcanceraliteraturereview AT adriansantoyosanchez novelcoronavirussarscov2outbreakandcanceraliteraturereview AT adolfomartineztovar novelcoronavirussarscov2outbreakandcanceraliteraturereview |